Join
Live feed
·
INSIDERFilingvia Quantisnow
Oncolytics Biotech Inc. logo

Chief Medical Officer Heineman Thomas Charles bought $10,033 worth of shares (12,132 units at $0.83), increasing direct ownership by 4% to 282,818 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ONCY· Oncolytics Biotech Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ONCY (Oncolytics Biotech Inc.) and more on Quantisnow.